Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Testing a New Imaging Agent to Identify Cancer - Drug Trials For Money - Paid Clinical Trials

Testing a New Imaging Agent to Identify Cancer

Testing a New Imaging Agent to Identify Cancer
Conditions:   HER-2 Positive Malignant Carcinoma of Breast;   HER-2 Protein Overexpression;   HER2-positive Metastatic Breast Cancer
Interventions:   Combination Product: 89Zr-ss-pertuzumab PET/CT;   Combination Product: 89Zr-pertuzumab PET/CT
Sponsors:   Memorial Sloan Kettering Cancer Center;   National Institutes of Health (NIH)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 6, 2021 / by / in
Comments